7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Dental Pulp Calcification D003784 2 associated lipids
Dental Pulp Exposure D003789 1 associated lipids
Dental Pulp Necrosis D003790 6 associated lipids
Dentin Dysplasia D003805 1 associated lipids
Dermatomyositis D003882 2 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetic Neuropathies D003929 5 associated lipids
Diarrhea D003967 32 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Disease Susceptibility D004198 12 associated lipids
Emphysema D004646 1 associated lipids
Encephalitis D004660 15 associated lipids
Endocrine System Diseases D004700 4 associated lipids
Endometriosis D004715 29 associated lipids
Eye Neoplasms D005134 2 associated lipids
Femur Head Necrosis D005271 5 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Gingival Recession D005889 2 associated lipids
Glioma D005910 112 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Graves Disease D006111 6 associated lipids
Heart Failure D006333 36 associated lipids
Heart Valve Diseases D006349 4 associated lipids
Hemarthrosis D006395 1 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Hemophilia A D006467 10 associated lipids
Hepatitis C D006526 7 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hip Dislocation D006617 1 associated lipids
Hip Fractures D006620 2 associated lipids
Hirsutism D006628 3 associated lipids
Histiocytosis, Langerhans-Cell D006646 1 associated lipids
HIV Seropositivity D006679 15 associated lipids
Hyperalgesia D006930 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hyperinsulinism D006946 27 associated lipids
Hyperparathyroidism D006961 3 associated lipids
Hyperparathyroidism, Secondary D006962 4 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Hypertension D006973 115 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Hypocalcemia D006996 12 associated lipids
Hypothyroidism D007037 32 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Dynybil C et al. [The effect of osteoprotegerin on tendon-bone healing after reconstruction of the anterior cruciate ligament: a histomorphological and radiographical study in the rabbit]. 2006 Mar-Apr Z Orthop Ihre Grenzgeb pmid:16625448
Endres S et al. [Comparative in vitro analysis of vacuum plasma-sprayed titanium implants--evaluation of OPG, Osteokalzin and AP expression]. 2006 Nov-Dec Z Orthop Ihre Grenzgeb pmid:17187340
An JJ et al. Expression and regulation of osteoprotegerin in adipose tissue. 2007 Yonsei Med. J. pmid:17963332
Xiao HL et al. [Expression and activity determination of TNFR domain of osteoprotegerin in E.coli and corresponding antibody preparation]. 2005 Yi Chuan pmid:16257908
Geng L et al. [Association between Val80 polymorphism of the CYP19 gene, A163G polymorphism of the OPG gene and bone mineral density in post-menopausal Chinese women]. 2007 Yi Chuan pmid:17989043
Ming LG et al. [Effect of osthol on apoptosis and bone resorption of osteoclasts cultured in vitro]. 2012 Yao Xue Xue Bao pmid:22512027
Qiu S et al. [Design and activity verification of human parathyroid hormone (1-34) mutant protein]. 2012 Yao Xue Xue Bao pmid:22993856
Wang L et al. [Inhibitory effect of diacerein on osteoclastic bone destruction and its possible mechanism of action]. 2006 Yao Xue Xue Bao pmid:16927832
Kang BH et al. [Expression of truncated fragment of human OPG in CHO-DHFR- cells and its bioactivity characterization]. 2009 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi pmid:19900367
Shao B et al. [RANKL and OPG expression in bone marrow-derived mesenchymal stem cells of ovariectomied promotes osteoclast development and enhances its function]. 2013 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi pmid:24321069
Miyaji Y et al. Pharmacokinetics and disposition of recombinant human osteoprotegerin (rhOPG) after intravenous administration in female fischer rats. 2009 Xenobiotica pmid:19255937
Larussa T et al. No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. 2012 World J. Gastroenterol. pmid:22529691
Sood SK et al. Osteoprotegerin (OPG) and related proteins (RANK, RANKL and TRAIL) in thyroid disease. 2011 World J Surg pmid:21748518
Fahrleitner-Pammer A et al. Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status. 2003 Wien. Klin. Wochenschr. pmid:12793029
Fahrleitner A et al. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status. 2002 Wien. Klin. Wochenschr. pmid:12602117
Wagner D and Fahrleitner-Pammer A Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: are they of any help? 2010 Wien Med Wochenschr pmid:20714810
Winzer M et al. Glycitein decreases the generation of murine osteoclasts and increases apoptosis. 2010 Wien Med Wochenschr pmid:20714813
Gruber R Cell biology of osteoimmunology. 2010 Wien Med Wochenschr pmid:20714814
Beke D et al. [Clinical relevance of biomarkers in cancer related bone disease]. 2007 Wien Med Wochenschr pmid:17922085
Kerschan-Schindl K Bone turnover in hyperparathyroidism. 2013 Wien Med Wochenschr pmid:22805761

Table of Content